Inhibition
Of Helicobacter Pylori
The 12 strains of lactic acid bacteria
in the OMX capsule showed antimicrobial activity against H.
pylori in vitro as shown by loss of viability of the latter.
A well diffusion assay technique was used. One OMX Capsule
was dissolved and incubated in All purpose Medium with Tween
(APT) broth with or without biotin for good recovery of the
organisms from the capsule. The results obtained in Table
5 is the mean of duplicate tests. The colonies recovered from
the capsule dissolved in water and then plated on APT agar
and de Man, Rogosa and Sharpe (MRS) agar showed decrease in
the number of colony forming units of the H.pylori strains
(NCTC11637 & NCTC11638).
This preliminary results explains how viable lactic acid bacteria
contained in live capsule based probiotic can bring about
much relief to those suffering from peptic ulcers and gastritis
by inhibiting the H.pylori infection.
GROWTH INHIBITION ON E. COLI 0157
The component from TH10 strain was extracted with ethyl acetate
and then neutralised by regulating the Ph. Then variable rates
(0.75, 1.5, 3.0, 6.0, 12 and 24 mg) of the lactic acid bacteria
extract were introduced on dipped paper discs into petri dishes
containing cultured viable colonies of E. coli 0157 in several
replicates. These petti dishes were incubated at 37 degrees
centigrade. Growth inhibitions of the 0157 strain were monitored
by observing the diameter of zones of inhibitions obtained
around the paper discs.
Results indicated that inhibition of 0157 were obtained at
all amounts of 3.0mg and above of the extract. Consistent
results were obtained on repetition. Inhibitory effects were
increased with more amount of the extract.
The substance acting on the 0157 strain is initially made
out to be of low molecular weight and further research is
being carried out to specify its structure and mechanism of
activity.
MODE OF ACTION
At this stage the explanation that can be offered is the action
of the different bacteriocins and the lowering of pH by the
OMX inhibiting the proliferation of the antagonistic microorganisms.
With the five years fermentation and low pH achieved it is
found that the acidolin produced by the Lactobacillus acidophilus
is particularly active against bacteria and viruses. This
evidence is further supported by earlier research of Hamdan
and Mikolajcik (1974). This makes OMX lactic acid bacteria
highly effective in terms of its antimicrobial property as
well as a functional food supplement.
REFERENCES
Lilley, DM and Stillwell, R H (1965). Probiotics: growth promoting
factors produced by microorganisms. Science 147 : 747 - 748
Parker, R B (1974). Probiotics, the other half of the antibiotic
story. Anim. Nutr.
Health 29 : 4 - 8.
Fuller, R (1989). Probiotics in man and animals. J. Appl.
Bacteriol. 66: 365 - 378.
Hamdan, I Y and Mikolajcik, E M (1974). Acidolin: an antibiotic
produced by Lactobacillus acidophilus. Journal of Antibiotics
8 : 631 - 636.
| TABLE 1: AMINO ACID CONTENTS
IN OMX CAPSULE SAMPLE |
| AMINO ACIDS |
11/100 |
| Arginine |
0.10 |
| Lysine |
0.10 |
| Histidine |
0.08 |
| Phenylalanine |
0.26 |
| Tyrosine |
0.14 |
| Lcucine |
0.41 |
| Isoleucine |
0.25 |
| Methionine |
0.05 |
| Valine |
0.28 |
| Alanine |
0.22 |
| Glycine |
0.19 |
| Proline |
0.42 |
| Glutamic acid |
1.11 |
| Serine |
0.22 |
| Threonine |
0.18 |
| Aspartic acid |
0.68 |
| Tryptophan |
0.04 |
| Cystine |
0.06 |
| TABLE 2: Level of essential
minerals in samples of ONIX capsules |
| Mineral |
Level (mg/ 100g) |
| Phosphorus |
176 |
| Iron |
4.07 |
| Calcium |
123 |
| Sodium |
58.6 |
| Potassium |
899 |
| TABLE 3: TO SHOW BIOSAFETY
OF OMX CAPSULE CONTENTS |
|
No. |
Heavy
metal |
Level
in OMX |
Permitted level(Food Regulation
Act 1985) |
| 01. |
Arscnic (As) |
0.22 |
1 |
| 02. |
Lead (Pb) |
0.07 |
2 |
| 03. |
Copper (Cu) |
0.53 |
30 |
| 04. |
Tin (Sn) |
0.04 |
40 |
| 05. |
Zinc (Zn) |
3.33 |
40 |
| 06. |
Mercury (Hg) |
Not detected |
0.05 |
| 07. |
Cadmium (Cd) |
Not detected |
1 |
| 08. |
Antimony (Sb) |
Not detected |
1 |
| 09. |
Total plate countof lactic
acidbacteria per capsule |
59,000,000 cfu |
|
| *parts per million (ppm), maximum |
| TABLE4
: |
INHIBITION OF ETHYL
ACETATE EXTRACT OF
ENTEROCOCCUS FAECALIS TH10 |
|
|
Test organism |
Dosage (mg)
20 10 5 |
| Methicillin resistant Staphylococcus aureus |
+ |
+ |
| Enterococcus faecalis RIMD 3116001 |
- |
- |
| Enterococcus faecium |
- |
- |
| Streptococciissalivarius |
+ |
- |
| Pediococcus pentosaceus |
- |
- |
| Lactococcus lactis subsp. Lactis |
- |
- |
| Leuconostoc mesenteroides subsp. Mesenteroides |
- |
- |
| Lactobacillus plantarum |
- |
- |
| Lactobacillus delbrueckii |
- |
- |
| Dry weight of the ethyl acetate extract+ Growth inhibition
of test organism around paper disk- No inhibition |
- |
- |
| TABLE5
: |
INHIBITION OF HELICOBACTER
PYLORI STRAINS (NCTC 11637 & 11638) AFTER 24
HRS IN WCACB BROTH WITH PREDISSOLVED OMX CAPSULE
FOR
18 HRS |
|
|
SAMPLES |
SAMPLES TIME |
| |
O hrs |
24 hrs |
| |
7 |
9 |
| H.pylori NCTC 11637 |
2 x 10 cfu / ml |
9 x 10 cfu / ml |
| |
7 |
4 |
| H.pylori NCTC 11637 + OMX capsule |
2 x 10 cfu / ml |
3 x 10 cfu / ml |
| |
7 |
9 |
| H.pylori NCTC 11638 |
5 x 10 cfu / ml |
8 x 10 cfu / ml |
| |
7 |
3 |
| H.pylori NCTC 11638 + OMX capsule |
5 x 10 cfu / ml |
8 x 10 cfu / ml |
^TOP
|